Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

October 20, 2020 00:31:24
Episode Cover

Electrical Storm

Although electrical storm is an uncommon presentation, it is important that we readily recognize and treat these patients to prevent rapid progression to cardiac...

Listen

Episode 0

October 25, 2018 00:29:40
Episode Cover

Analgesia & Sedation in the Critically Ill

Untreated pain, anxiety, and agitation have both short- and long-term consequences for our critically ill patients.  More importantly, it is well-known that patients remember...

Listen

Episode 0

September 19, 2017 00:32:38
Episode Cover

ED Mechanical Ventilation Pearls

In this podcast we discuss the pearls and perils of ED mechanical ventilation.  What are the numbers you NEED to know! We also discuss...

Listen